Kwan, Jason C.


Publications
3

Increased Biosynthetic Gene Dosage in a Genome-Reduced Defensive Bacterial Symbiont

Citation
Lopera et al. (2017). mSystems 2 (6)
Names
“Didemniditutus” “Didemniditutus mandelae”
Abstract
Secondary metabolites, which are small-molecule organic compounds produced by living organisms, provide or inspire drugs for many different diseases. These natural products have evolved over millions of years to provide a survival benefit to the producing organism and often display potent biological activity with important therapeutic applications. For instance, defensive compounds in the environment may be cytotoxic to eukaryotic cells, a property exploitable for cancer treatment. Here, we desc

Lack of Overt Genome Reduction in the Bryostatin-Producing Bryozoan Symbiont “Candidatus Endobugula sertula”

Citation
Miller et al. (2016). Applied and Environmental Microbiology 82 (22)
Names
“Endobugula sertula”
Abstract
ABSTRACT The uncultured bacterial symbiont “ Candidatus Endobugula sertula” is known to produce cytotoxic compounds called bryostatins, which protect the larvae of its host, Bugula neritina . The symbiont has never been successfully cultured, and it was thought that its genome might be significantly reduced. Here, we took a shotgun metagenomics and metatranscriptomics approach to assemble and characterize the genome of “

Genome streamlining and chemical defense in a coral reef symbiosis

Citation
Kwan et al. (2012). Proceedings of the National Academy of Sciences 109 (50)
Names
“Endolissoclinum faulkneri”
Abstract
Secondary metabolites are ubiquitous in bacteria, but by definition, they are thought to be nonessential. Highly toxic secondary metabolites such as patellazoles have been isolated from marine tunicates, where their exceptional potency and abundance implies a role in chemical defense, but their biological source is unknown. Here, we describe the association of the tunicate Lissoclinum patella with a symbiotic α-proteobacterium, Candidatus